The EPS projection of Clorox Company (The) (NYSE:CLX) for quarter ended 2016-09-30 is $1.38. A week before, the EPS forecast was $1.38 against target of $1.38, a month earlier. This estimate stood at $1.38 60 days earlier versus forecast of $1.38 90 days earlier, confirming a deviation of 0%.
Clorox Company (The) (NYSE:CLX) reported that 18 days ago, the positive EPS revisions were 3 and negative revisions at 0.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 2, 1, 0 and 2, respectively.
The downgrade of EPS estimates for Clorox Company (The) (NYSE:CLX) in the preceding 120, 60, 30 and 90 days were 0, 0, 0 and 0, in that order.
As per the latest update, for the quarter closed 3, the EPS estimate of Clorox Company (The) (NYSE:CLX) was $1.38. This projection was computed after accounting 7 calls. As reported on 2016-05-03 the EPS was $1.21. The change was $0.11, demonstrating a percentage deviation of 10%. The projections confirmed a standard deviation of 0.03.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for Clorox Company (The) (NYSE:CLX) stands at $1642.212 and the median estimate at $1643.425. Almost 4 analysts announced their estimates.
The highest estimate is $1668 while the lowest target is $1614 showing standard deviation of 22.281%.
As many as 4 analysts released sales estimates reised in upside while 4 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 4 revised sales number projection on upside while 4 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 4 hiked sales estimations and 4 reduced sales forecast. Clorox Company (The) (NYSE:CLX) stated that the change in forecast was 3.243%.
1 Chart Pattern Every Investor Should Know